We’re excited to be here at CPHI India 2025! Visit us at Stand 1C19 and join us at CPHI India as we connect with industry leaders, explore innovative solutions, and share insights about the future of pharmaceuticals. If you’re attending, come meet us and let’s discuss how we can collaborate to drive progress together! #CPHIIndia #PharmaInnovation #Networking #Collaboration #APIs
Olon
Fabbricazione di prodotti chimici
Milan, Lombardia 65.731 follower
Sustainable technologies delivering science
Chi siamo
Olon is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and Generics. We supply more than 300 Active Pharmaceutical Ingredients globally, with one of the most extensive track records in the industry. We provide an integrated package of chemical synthesis and biological processing services which clients can use to manage their drug manufacturing projects fully compliant with regulations. We rely on the broadest technical expertise while maintaining a long-standing quality and reliability Thanks to 2.800 employees and 300 highly experienced and qualified people in R&D team, we are a highly reliable partner. Our global manufacturing networks implies 14 manufacturing sites and 14 R&D departments across the globe, on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies.
- Sito Web
-
http://olonspa.com
Link esterno per Olon
- Settore
- Fabbricazione di prodotti chimici
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- Milan, Lombardia
- Tipo
- Società privata non quotata
- Data di fondazione
- 2003
- Settori di competenza
- API e CDMO
Località
Dipendenti presso Olon
Aggiornamenti
-
We’re in sunny San Diego for World ADC San Diego 2025 and couldn’t be more excited to connect with the amazing people driving the future of Antibody-Drug Conjugates! If you’re here too, make sure to stop by the Olon booth # 18 Let’s chat about innovation, collaboration, and how Olon’s CDMO expertise can help bring complex molecules to life. We love talking science (and meeting great people), so come say hi! #Olon #WorldADCSanDiego #CDMO #Innovation
-
-
Hello from #BIO-Europe. Our team is here and ready to connect. Come find us at the Italian Pavilion, booth #C60, and say hi! #BIOEurope #Vienna #Biotech
-
-
What an inspiring CPHI Frankfurt! We enjoyed meaningful conversations, valuable connections, and great teamwork. Meeting partners, clients, and colleagues from across the industry, sharing ideas, and exploring new opportunities made this event truly memorable. We leave with insights, memories and renewed motivation. Already looking forward to seeing you all next year in Milan! #CPHI #PharmaIndustry #Innovation
-
-
What an inspiring start to CPHI Frankfurt 2025! On the opening day, Roberta Pizzocaro, President of Olon and Board Member of EFCG, joined an insightful conference session: “The Critical Medicines Act: Game-Changing Opportunity for a Sustainable and Resilient Supply Chain?” It was wonderful to see so many engaged minds in the room, thank you for making the conversation so enriching. Rebecca Guntern Maggie Saykali Martin J. Klatt #CPHIFrankfurt #Olon #EFCG #PharmaInnovation #CriticalMedicinesAct #Sustainability #ResilientSupplyChain
-
-
Discover Olon’s Global ADC Expertise! Discover our fully integrated, end-to-end ADC manufacturing capabilities, advances in impurity control, and new facilities dedicated to ultra-potent OEB6 compounds. Explore how strategic acquisitions and our forward-looking vision are shaping the next generation of high-potency therapeutics. Listen to the full deep dive here: https://vist.ly/4bgni #ADC #Biotech #Innovation #GMP #Pharma #Olon
-
We are so excited to share this news! 🤝 Olon and Ajinomoto Bio-Pharma Services are joining forces to expand global access to advanced peptide and protein manufacturing. By combining Olon’s GMP fermentation expertise with Ajinomoto’s CORYNEX® technology, we’re enabling efficient, scalable, and sustainable production of next-generation therapeutics. Innovation and partnership, powering a healthier future. 🌱 Read the full press release here: http://bit.ly/4nqeDu2 #Olon #AjinomotoBioPharmaServices #Partnership #Biotech #Pharma #GLP1 #Innovation #Biomanufacturing #Sustainability #LifeSciences #Collaboration
Ajinomoto Bio-Pharma Services and Olon are partnering to expand access to advanced peptide and protein manufacturing for pharmaceutical and biotech clients worldwide. This collaboration combines CORYNEX® microbial expression technology with Olon’s large-scale GMP fermentation expertise, creating a seamless path from development to commercial-scale production. Together, we’re enabling efficient, sustainable manufacturing of high-demand therapeutics, including GLP-1 analogs that are transforming the treatment landscape for obesity and type II diabetes. A powerful partnership built on innovation, scalability, and impact. Read the full press release here: http://bit.ly/4nqeDu2
-
The Olon team is ready for CPhI Frankfurt 2025! One Brand. One Story. Many Capabilities. Olon arrives at CPhI Frankfurt amid strong investment momentum across its international network. These upgrades enhance our ability to manage fully integrated development programs , from process design and scale-up through validation and commercial manufacturing for both chemical and biological products. Visit us at # 5.0 D92. See you in Frankfurt! #CPHI #Biotech #Pharma #ADC #Innovation #SupplyChain #Olon https://lnkd.in/dNTiBZKv
-
The Olon team is ready for World ADC San Diego 2025! We’re looking forward to connecting with the innovators driving the next generation of antibody-drug conjugates. Whether you’re advancing early discovery or scaling up to commercial manufacturing, stop by Booth 18 to learn how Olon can support your ADC journey. See you in San Diego! #ADCSanDiego2025 #CDMO #AntibodyDrugConjugates #Olon
-
-
Don’t Miss This Exclusive Webinar on Scaling Biomanufacturing 🚀 🔗 Register now: https://lnkd.in/g98JH6UQ 👉 Secure your spot today and be part of the conversation shaping the future of biomanufacturing!
🧬 Scaling up from lab to commercial production — let’s talk about it! Moving from lab innovation to large-scale manufacturing brings unique challenges… and valuable lessons. Join Deborah Davies (Olon) and Cat Huyer (Synonym) this Wednesday, October 15 at 11am ET / 4pm BST, for a candid discussion on: 🔹 Critical decision points in the scale-up journey 🔹 Real-world insights from food, personal care, and CPG sectors 🔹 Practical takeaways for successful biomanufacturing partnerships Whether you’re developing functional ingredients, reformulating, or designing sustainable solutions, this webinar will give you actionable intelligence for your next strategic move. 🎟️ Save your spot: https://lnkd.in/g98JH6UQ